Cargando…
The Anti-Diabetic Drug Metformin Protects against Chemotherapy-Induced Peripheral Neuropathy in a Mouse Model
Chemotherapy-induced peripheral neuropathy (CIPN) characterized by loss of sensory sensitivity and pain in hands and feet is the major dose-limiting toxicity of many chemotherapeutics. At present, there are no FDA-approved treatments for CIPN. The anti-diabetic drug metformin is the most widely used...
Autores principales: | Mao-Ying, Qi-Liang, Kavelaars, Annemieke, Krukowski, Karen, Huo, Xiao-Jiao, Zhou, Wenjun, Price, Theodore J., Cleeland, Charles, Heijnen, Cobi J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4067328/ https://www.ncbi.nlm.nih.gov/pubmed/24955774 http://dx.doi.org/10.1371/journal.pone.0100701 |
Ejemplares similares
-
Inhibition of Mitochondrial p53 Accumulation by PFT-μ Prevents Cisplatin-Induced Peripheral Neuropathy
por: Maj, Magdalena A., et al.
Publicado: (2017) -
Metformin Prevents Cisplatin-Induced Cognitive Impairment and Brain Damage in Mice
por: Zhou, Wenjun, et al.
Publicado: (2016) -
Mechanisms of chemotherapy-induced behavioral toxicities
por: Vichaya, Elisabeth G., et al.
Publicado: (2015) -
Cisplatin treatment induces attention deficits and impairs synaptic integrity in the prefrontal cortex in mice
por: Huo, XiaoJiao, et al.
Publicado: (2018) -
Pharmacological inhibition of HDAC6 reverses cognitive impairment and tau pathology as a result of cisplatin treatment
por: Ma, Jiacheng, et al.
Publicado: (2018)